I agree that this site is using cookies. You can find further informations here.
X
Xavier Leleu
683  results:
Search for persons X
?
1

Isatuximab plus pomalidomide and dexamethasone in patients ..:

Decaux, Olivier ; Fontan, Jean ; Perrot, Aurore...
European Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

A.R.R.O.W.2: Once- vs twice-weekly carfilzomib, lenalidomid..:

Dimopoulos, Meletios-Athanasios A. ; Coriu, Daniel ; Delimpasi, Sosana...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
3

Impact of prior lenalidomide or proteasome inhibitor exposu..:

Lee, Hans C. ; Ramasamy, Karthik ; Macro, Margaret...
European Journal of Haematology.  113 (2024)  2 - p. 190-200 , 2024
Link: https://doi.org/10.1111/..
 
?
4

Belantamab mafodotin: an important treatment option for vul..:

Mateos, Maria Victoria ; Weisel, Katja ; Terpos, Evangelos...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
5

Daratumumab, carfilzomib, lenalidomide, and dexamethasone w..:

Touzeau, Cyrille ; Perrot, Aurore ; Hulin, Cyrille...
Blood.  143 (2024)  20 - p. 2029-2036 , 2024
Link: https://doi.org/10.1182/..
 
?
6

Impact of prior treatment on selinexor, bortezomib, dexamet..:

Mateos, Maria‐Victoria ; Engelhardt, Monika ; Leleu, Xavier...
European Journal of Haematology.  113 (2024)  2 - p. 242-252 , 2024
Link: https://doi.org/10.1111/..
 
?
7

Effectiveness and safety of belantamab mafodotin in patient..:

Roussel, Murielle ; Texier, Nathalie ; Nael, Virginie...
European Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
8

International Myeloma Working Group immunotherapy committee..:

Rodriguez-Otero, Paula ; Usmani, Saad ; Cohen, Adam D...
The Lancet Oncology.  25 (2024)  5 - p. e205-e216 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Bortezomib, thalidomide, and dexamethasone with or without ..:

Moreau, Philippe ; Hulin, Cyrille ; Perrot, Aurore...
The Lancet Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
10

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenal..:

Weisel, Katja ; Dimopoulos, Meletios A. ; Beksac, Meral...
Leukemia & Lymphoma.  65 (2024)  4 - p. 481-492 , 2024
Link: https://doi.org/10.1080/..
 
?
11

INSURE: a pooled analysis of ixazomib-lenalidomide-dexameth..:

Leleu, Xavier ; Lee, Hans C ; Zonder, Jeffrey A...
Future Oncology.  20 (2024)  14 - p. 935-950 , 2024
Link: https://doi.org/10.2217/..
 
?
12

Venous thromboembolism prophylaxis and multiple myeloma pat..:

Frenzel, Laurent ; Decaux, Olivier ; Macro, Margaret...
Thrombosis Research.  233 (2024)  - p. 153-164 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Long-term outcomes and renal responses following autologous..:

Garderet, Laurent ; Gras, Luuk ; Koster, Linda...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
14

How I treat multiple myeloma in geriatric patients:

Facon, Thierry ; Leleu, Xavier ; Manier, Salomon
Blood.  143 (2024)  3 - p. 224-232 , 2024
Link: https://doi.org/10.1182/..
 
?
15

Isatuximab, lenalidomide, dexamethasone and bortezomib in t..:

Leleu, Xavier ; Hulin, Cyrille ; Lambert, Jerome...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
1-15